Tree-in-bud Pattern in ALK-positive Lung Adenocarcinoma

por Shiroyama, Takayuki, Nasu, Shingo, Tanaka, Ayako, Hirashima, Tomonori
Publicado 2020

Important factors for achieving survival of five years or more in non-small cell lung cancer patients with distant metastasis

por HIRASHIMA, TOMONORI, SUZUKI, HIDEKAZU, OKAMOTO, NORIO, MORISHITA, NAOKO, YAMADORI, TADAHIRO, TAMIYA, MOTOHIRO, SHIROYAMA, TAKAYUKI, KURATA, KANAKO, KAWASE, ICHIRO
Publicado 2014

A case of renal cell carcinoma with late recurrence in the bilateral hilar lymph nodes twenty years after surgery

por Sakurai, Yusuke, Matsuura, Hiroyuki, Oshima, Yuri, Hirai, Kaho, Tani, Eriko, Yoshimoto, Naoki, Minami, Kenichi, Wakasa, Kenichi, Hirashima, Tomonori
Publicado 2022

The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations

por Suzuki, Hidekazu, Hirashima, Tomonori, Okamoto, Norio, Yamadori, Tadahiro, Tamiya, Motohiro, Morishita, Naoko, Shiroyama, Takayuki, Otsuka, Tomoyuki, Kitai, Kanako, Kawase, Ichiro
Publicado 2013

Successful retreatment with osimertinib after osimertinib-induced acute pulmonary embolism in a patient with lung adenocarcinoma: A case report

por Shiroyama, Takayuki, Hayama, Manabu, Satoh, Shingo, Nasu, Shingo, Tanaka, Ayako, Morita, Satomu, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Hirashima, Tomonori
Publicado 2016

Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma

por Satoh, Shingo, Shiroyama, Takayuki, Tamiya, Motohiro, Nasu, Shingo, Tanaka, Ayako, Morita, Satomu, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Hirashima, Tomonori
Publicado 2017

The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC

por Tamiya, Motohiro, Tamiya, Akihiro, Okamoto, Norio, Taniguchi, Yoshihiko, Nishino, Kazumi, Atagi, Shinji, Hirashima, Tomonori, Imamura, Fumio, Kumagai, Toru, Suzuki, Hidekazu
Publicado 2021

A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia

por Oshima, Yuri, Matsuura, Hiroyuki, Sakurai, Yusuke, Hirai, Kaho, Tani, Eriko, Yoshimoto, Naoki, Minami, Kenichi, Yamasaki, Fumio, Nishime, Mayu, Hirashima, Tomonori
Publicado 2022

Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma with G719S, S768I, and T790M Mutations

por Nasu, Shingo, Shiroyama, Takayuki, Morita, Satomu, Takata, So, Takada, Hiromune, Masuhiro, Kentaro, Tanaka, Ayako, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Hirashima, Tomonori
Publicado 2018

Acromegaly Initially Presenting with Severe Infectious Diseases: A Case Report

por Tani, Eriko, Hirashima, Tomonori, Hasegawa, Takamasa, Aohara, Daisuke, Oshima, Yuri, Sakurai, Yusuke, Hirai, Kaho, Yoshimoto, Naoki, Nishida, Mana, Tateishi, Yu, Minami, Kenichi
Publicado 2021

Radial endobronchial ultrasound with a guide sheath for diagnosis of peripheral cavitary lung lesions: a retrospective study

por Hayama, Manabu, Okamoto, Norio, Suzuki, Hidekazu, Tamiya, Motohiro, Shiroyama, Takayuki, Tanaka, Ayako, Nishida, Takuji, Nishihara, Takashi, Uehara, Nobuko, Morishita, Naoko, Kawahara, Kunimitsu, Hirashima, Tomonori
Publicado 2016

Transformation to small cell lung cancer after first-line afatinib treatment

por Shiroyama, Takayuki, Nasu, Shingo, Tanaka, Ayako, Takata, So, Masuhiro, Kentaro, Takada, Hiromune, Morita, Satomu, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Kawahara, Kunimitsu, Hirashima, Tomonori
Publicado 2018

A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102

por Yokoi, Takashi, Minami, Seigo, Shiroyama, Takayuki, Koba, Taro, Torii, Yoshitaro, Sugimoto, Hiroyuki, Niki, Maiko, Mori, Masahide, Morimura, Osamu, Hirashima, Tomonori, Komuta, Kiyoshi, Kijima, Takashi
Publicado 2019

Effectiveness of EGFR tyrosine kinase inhibitors in advanced non‐small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational study

por Kanazu, Masaki, Mori, Masahide, Kimura, Madoka, Nishino, Kazumi, Shiroyama, Takayuki, Nagatomo, Izumi, Ihara, Shoichi, Komuta, Kiyoshi, Suzuki, Hidekazu, Hirashima, Tomonori, Kumagai, Toru, Imamura, Fumio
Publicado 2020

Relationship between the Pharmacokinetics of Irinotecan and Diarrhea during Combination Chemotherapy with Cisplatin

por Kudoh, Shinzoh, Fukuoka, Masahiro, Masuda, Noriyuki, Yoshikawa, Atsuko, Kusunoki, Yoko, Matsui, Kaoru, Negoro, Shun‐ichi, Takifuji, Nobuhide, Nakagawa, Kazuhiko, Hirashima, Tomonori, Yana, Takashi, Takada, Minoru
Publicado 1995

Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group

por Murakami, Haruyasu, Yamanaka, Takeharu, Seto, Takashi, Sugio, Kenji, Okamoto, Isamu, Sawa, Toshiyuki, Hirashima, Tomonori, Takeda, Koji, Atagi, Shinji, Fukuoka, Masahiro, Nakanishi, Yoichi, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki
Publicado 2014

Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer

por Nakao, Keiko, Kobuchi, Shinji, Marutani, Shuhei, Iwazaki, Ayano, Tamiya, Akihiro, Isa, Shunichi, Okishio, Kyoichi, Kanazu, Masaki, Tamiya, Motohiro, Hirashima, Tomonori, Imai, Kimie, Sakaeda, Toshiyuki, Atagi, Shinji
Publicado 2019

Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study

por Matsumoto, Kinnosuke, Tamiya, Akihiro, Matsuda, Yoshinobu, Taniguchi, Yoshihiko, Atagi, Shinji, Kawachi, Hayato, Tamiya, Motohiro, Tanizaki, Satoshi, Uchida, Junji, Ueno, Kiyonobu, Yanase, Takafumi, Suzuki, Hidekazu, Hirashima, Tomonori
Publicado 2021

Scoring system for identifying Japanese patients with COVID-19 at risk of requiring oxygen supply: A retrospective single-center study

por Kitajima, Heita, Hirashima, Tomonori, Suzuki, Hidekazu, Arai, Tsuyoshi, Tamura, Yoshitaka, Hashimoto, Shoji, Morishita, Hiroshi, Matsuoka, Hiroto, Kashiwa, Yozo, Han, Yuki, Minamoto, Seijiro, Tanaka, Toshio, Nagai, Takayuki
Publicado 2021

Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer

por Shiroyama, Takayuki, Suzuki, Hidekazu, Tamiya, Motohiro, Tamiya, Akihiro, Tanaka, Ayako, Okamoto, Norio, Nakahama, Kenji, Taniguchi, Yoshihiko, Isa, Shun‐ichi, Inoue, Takako, Imamura, Fumio, Atagi, Shinji, Hirashima, Tomonori
Publicado 2017